Day Traders Tag icon

×
10x Genomics Inc (NASDAQ:TXG) stock is trading lower after the company, on Wednesday, released preliminary financial results for the third quarter of 2024, revealing a mixed performance. The company’s revenue for the quarter totaled approximately $151.7 million versus the consensus of $162.245 million, marking a slight 1% decline compared to the same period in 2023. Also Read: What’s Going On With 10x Genomics Stock On Wednesday? “Third-quarter revenue fell short of our expectations,” said Serge Saxonov, Co-founder and CEO of 10x Genomics. “The previously announced modifications we made to our commercial processes and organization to increase effectiveness represented a significant change in ...


In The news